Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1-positive locally advanced/metastatic NSCLC

Mok T. S. K. , Wu Y., Kudaba I., Kowalski D. M. , Cho B. C. , Turna H. Z. , ...More

European Lung Cancer Congress (ELCC), Geneva, Switzerland, 10 - 13 April 2019, vol.30, pp.38 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 30
  • City: Geneva
  • Country: Switzerland
  • Page Numbers: pp.38
  • Istanbul University Affiliated: Yes